Found: 29
Select item for more details and to access through your institution.
Galderma Labs. v. Tolmar Inc.: Determining the contours of when a claimed concentration is obvious in view of a prior art range of concentrations.
- Published in:
- Journal of Generic Medicines, 2014, v. 11, n. 3/4, p. 157, doi. 10.1177/1741134314560834
- By:
- Publication type:
- Article
Sunovion v. Teva and Reddy: Reddy’s promise not to infringe was insufficient to avoid infringement.
- Published in:
- Journal of Generic Medicines, 2014, v. 11, n. 1/2, p. 84, doi. 10.1177/1741134314553140
- By:
- Publication type:
- Article
Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.: Was the decision to selectively present evidence of commercial success too “clever by half”?
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Pozen Inc. v. Par Pharmaceutical, Inc.: “Fuzzy” limitations and the doctrine of equivalents.
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 2, p. 139, doi. 10.1177/1741134313515666
- By:
- Publication type:
- Article
Santarus, Inc. v. Par Pharmaceutical, Inc.: Is there a new written description requirement for negative limitations?
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 1, p. 53, doi. 10.1177/1741134313481035
- By:
- Publication type:
- Article
Novo Nordisk v.. Caraco: Who defines the use code narrative?
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 4, p. 223, doi. 10.1177/1741134312470124
- By:
- Publication type:
- Article
Caraco v. Novo Nordisk: Breathing life into the MMA’s counterclaim provision.
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 3, p. 154, doi. 10.1177/1741134312456694
- By:
- Publication type:
- Article
Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.: Reformulating an old drug is not as obvious as one might think.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Sanofi-Aventis et al. v. Apotex Inc. et al.: The one hundred eight million dollar question.
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 2, p. 100, doi. 10.1177/1741134312445867
- By:
- Publication type:
- Article
The America Invents Act: Post-grant review and paragraph IV certifications.
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 1, p. 5, doi. 10.1177/1741134311435766
- By:
- Publication type:
- Article
In re Brimonidine Patent Litigation: No infringement based on ANDA specifications and no invalidity based on an “obvious to try” analysis.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 4, p. 245, doi. 10.1177/1741134311428103
- By:
- Publication type:
- Article
AstraZeneca v. Apotex: Section viii statement or approved label – a Hobson’s choice?
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 3, p. 182, doi. 10.1177/1741134311416703
- By:
- Publication type:
- Article
Abbott v. Sandoz: Judicial clarity on the interpretation of product-by-process claims.
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 4, p. 369, doi. 10.1057/jgm.2009.30
- By:
- Publication type:
- Article
Photocure ASA v. Kappos et al and Actavis Elizabeth LLC v. USFDA: The Meaning of ‘Active Ingredient’ in the Hatch–Waxman Act.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 1, p. 41, doi. 10.1057/jgm.2011.2
- By:
- Publication type:
- Article
Novo Nordisk v. Caraco: Beware the perils of an overbroad use code.
- Published in:
- Journal of Generic Medicines, 2010, v. 7, n. 4, p. 371, doi. 10.1057/jgm.2010.30
- By:
- Publication type:
- Article
AstraZeneca v. Dr Reddy's: Overly aggressive litigation has its limits.
- Published in:
- Journal of Generic Medicines, 2010, v. 7, n. 3, p. 275, doi. 10.1057/jgm.2010.15
- By:
- Publication type:
- Article
Prometheus v. Mayo: Is 35 U.S.C. § 101 a viable defense to patents claiming methods of optimizing therapeutic efficacy?
- Published in:
- Journal of Generic Medicines, 2010, v. 7, n. 2, p. 185, doi. 10.1057/jgm.2010.3
- By:
- Publication type:
- Article
Amgen v. International Trade Commission: The 271(e)(1) safe harbor provision and ITC jurisdiction in section 337 proceedings.
- Published in:
- Journal of Generic Medicines, 2010, v. 7, n. 1, p. 74, doi. 10.1057/jgm.2009.42
- By:
- Publication type:
- Article
Merck v Apotex and its aftermath: Did Apotex have the last laugh?
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 3, p. 253, doi. 10.1057/jgm.2009.15
- By:
- Publication type:
- Article
Abbott v. Sandoz: If at first you don't succeed, try, try again.
- Published in:
- Journal of Generic Medicines, 2009, v. 6, n. 2, p. 145, doi. 10.1057/jgm.2008.34
- By:
- Publication type:
- Article
Ortho-McNeil v Mylan: Multiple summary judgment rulings for patentee including one on the meaning of ‘And’.
- Published in:
- Journal of Generic Medicines, 2008, v. 6, n. 1, p. 57, doi. 10.1057/jgm.2008.23
- By:
- Publication type:
- Article
Abbott v Torpharm: The Contours of Contempt.
- Published in:
- 2008
- By:
- Publication type:
- Case Study
Aventis v Lupin: Obviousness of purified stereoisomers in view of mixtures thereof.
- Published in:
- Journal of Generic Medicines, 2008, v. 5, n. 3, p. 219, doi. 10.1057/jgm.2008.2
- By:
- Publication type:
- Article
Pfizer v Apotex: What is the current standard of obviousness under 35 USC § 103?
- Published in:
- Journal of Generic Medicines, 2007, v. 5, n. 1, p. 53, doi. 10.1057/palgrave.jgm.4950090
- By:
- Publication type:
- Article
In re Metoprolol Succinate Patent Litigation: Composition claims render later product claims invalid for obviousness-type double patenting.
- Published in:
- Journal of Generic Medicines, 2008, v. 5, n. 2, p. 131, doi. 10.1057/palgrave.jgm.4950096
- By:
- Publication type:
- Article
Abbott v. Andrx: Earlier preliminary injunction rulings are not collateral estoppel.
- Published in:
- Journal of Generic Medicines, 2007, v. 4, n. 4, p. 267, doi. 10.1057/palgrave.jgm.4950076
- By:
- Publication type:
- Article
Early-onset and uncontrolled diabetes mellitus factors correlate with complications of Peyronie's disease.
- Published in:
- Journal of Sexual Medicine, 2024, v. 21, n. 8, p. 716, doi. 10.1093/jsxmed/qdae069
- By:
- Publication type:
- Article
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Ervin H. Zube (1931-2002).
- Published in:
- Environment & Behavior, 2003, v. 35, n. 2, p. 165, doi. 10.1177/0013916502250131
- By:
- Publication type:
- Article